Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.5
From GxPlex
| Document information | |
|---|---|
| Reference | ICH ICH E6 Guideline R3 (2025) |
| Validity area | ICH |
| Scope(s) | HM |
| Document name | ICH E6 Guideline |
| Version / Revision | R3 (2025) |
| Status | Current |
| Document type | International guideline |
| Language(s) | EN |
| Description | GUIDELINE FOR GOOD CLINICAL PRACTICE |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 2 â Unit 2.3.4 |
| Scope | G |
| Document part | III. Annex 1
3.5 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Written agreement, Sponsor, Documentation, Investigator |
| Comment | Financial documentation and agreements between sponsor and investigator |
Content
3.5 Financing The financial aspects of the trial should be documented in an agreement between the sponsor and the investigator/institution.
